Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
synthetic vitamin D analog |
| gptkbp:approvalYear |
1998
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
H05BX02
|
| gptkbp:brand |
Zemplar
|
| gptkbp:CASNumber |
131918-61-1
|
| gptkbp:developedBy |
gptkb:Abbott_Laboratories
|
| gptkbp:eliminationHalfLife |
14-20 hours
|
| gptkbp:excretion |
biliary
|
| gptkbp:hasMolecularFormula |
C27H44O3
|
| https://www.w3.org/2000/01/rdf-schema#label |
paricalcitol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
vitamin D receptor agonist
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
46853
DB00910 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
gptkb:hypercalcemia
nausea diarrhea edema |
| gptkbp:UNII |
Y59JL2A8NO
|
| gptkbp:usedFor |
gptkb:secondary_hyperparathyroidism
chronic kidney disease |
| gptkbp:bfsParent |
gptkb:calcitriol
|
| gptkbp:bfsLayer |
5
|